Polly Pine

2.6k total citations
24 papers, 1.6k citations indexed

About

Polly Pine is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Polly Pine has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Polly Pine's work include Mast cells and histamine (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Asthma and respiratory diseases (4 papers). Polly Pine is often cited by papers focused on Mast cells and histamine (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Asthma and respiratory diseases (4 papers). Polly Pine collaborates with scholars based in United States, Türkiye and Canada. Polly Pine's co-authors include Betty Chang, Donald G. Payan, George C. Tsokos, Frances Rena Bahjat, Elliott B. Grossbard, Guo‐Min Deng, Lena Liu, Erwin W. Gelfand, Feifei Zhao and Yasumichi Hitoshi and has published in prestigious journals such as Blood, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Polly Pine

23 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Polly Pine United States	15	1.0k	357	337	306	245	24	1.6k
Katrin Moser Germany	14	923 0.9×	171 0.5×	363 1.1×	425 1.4×	146 0.6×	15	1.6k
Silke Meister Germany	16	889 0.9×	231 0.6×	630 1.9×	297 1.0×	123 0.5×	26	1.8k
Hirokazu Ikeda Japan	20	1.1k 1.0×	252 0.7×	738 2.2×	239 0.8×	412 1.7×	70	2.1k
Debra M. Meyer United States	11	411 0.4×	393 1.1×	195 0.6×	464 1.5×	152 0.6×	13	1.2k
Michael I. Jesson United States	13	467 0.5×	666 1.9×	274 0.8×	502 1.6×	195 0.8×	21	1.6k
Karoline Sonneck Austria	23	1.0k 1.0×	360 1.0×	519 1.5×	411 1.3×	374 1.5×	40	1.9k
Jean S. Beebe United States	19	415 0.4×	314 0.9×	636 1.9×	257 0.8×	46 0.2×	39	1.7k
Katrina Wood United Kingdom	23	770 0.8×	703 2.0×	699 2.1×	128 0.4×	235 1.0×	61	2.4k
Ann‐Christine Syvänen Sweden	15	882 0.9×	329 0.9×	404 1.2×	759 2.5×	55 0.2×	22	1.6k
Massimiliano Bonifacio Italy	23	552 0.5×	802 2.2×	345 1.0×	279 0.9×	417 1.7×	88	2.2k

Countries citing papers authored by Polly Pine

Since Specialization

Citations

This map shows the geographic impact of Polly Pine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polly Pine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polly Pine more than expected).

Fields of papers citing papers by Polly Pine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polly Pine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polly Pine. The network helps show where Polly Pine may publish in the future.

Co-authorship network of co-authors of Polly Pine

This figure shows the co-authorship network connecting the top 25 collaborators of Polly Pine. A scholar is included among the top collaborators of Polly Pine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polly Pine. Polly Pine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Putta, Santosh, Bradford A. Young, Polly Pine, et al.. (2024). Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) After Hematopoietic Cell Transplantation (HCT). Transplantation and Cellular Therapy. 30(10). 986.e1–986.e7.

Putta, Santosh, Bradford A. Young, John E. Levine, et al.. (2022). Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy. 29(3). 166.e1–166.e10. 4 indexed citations

Ashino, Shigeru, Katsuyuki Takeda, Hui Li, et al.. (2013). Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses. Journal of Allergy and Clinical Immunology. 133(4). 1162–1174.e4. 58 indexed citations

Taylor, Vanessa, Chi Young, Linda Ste. Marie, et al.. (2012). R256 Is A Potent And Selective IL-13/4 Receptor Signaling Inhibitor That Reduces Inflammation In A Mouse Model Of Chronic Asthma. A2843–A2843. 2 indexed citations

Holland, Sacha J., Alison Pan, Christian Franci, et al.. (2010). R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer. Cancer Research. 70(4). 1544–1554. 429 indexed citations

Pamuk, Ömer Nurı, Peter H. Lapchak, Poonam Rani, et al.. (2010). Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion. American Journal of Physiology-Gastrointestinal and Liver Physiology. 299(2). G391–G399. 36 indexed citations

Deng, Guo‐Min, Lena Liu, Frances Rena Bahjat, Polly Pine, & George C. Tsokos. (2010). Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus‐prone mice. Arthritis & Rheumatism. 62(7). 2086–2092. 134 indexed citations

Chang, Betty, Feifei Zhao, Xiaodong He, et al.. (2009). JAK3 Inhibition Significantly Attenuates Psoriasiform Skin Inflammation in CD18 Mutant PL/J Mice. The Journal of Immunology. 183(3). 2183–2192. 56 indexed citations

Alley, Michael C., et al.. (2008). Preclinical pharmacologic evaluations of R406/R788, a multi-kinase inhibitor which exhibits unique, differential in vitro anticancer activity as well as in vivo antitumor efficacy following oral adminstration.. Cancer Research. 68. 4889–4889. 1 indexed citations

10.

Bahjat, Frances Rena, Polly Pine, Andrea Reitsma, et al.. (2008). An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis & Rheumatism. 58(5). 1433–1444. 137 indexed citations

11.

Young, Ryan M., Ian R. Hardy, Raedun Clarke, et al.. (2008). Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target. Blood. 113(11). 2508–2516. 101 indexed citations

12.

Krishnan, Sandeep, Bhabadeb Chowdhury, Carolyn U. Fisher, et al.. (2008). Differential Expression and Molecular Associations of Syk in Systemic Lupus Erythematosus T Cells. The Journal of Immunology. 181(11). 8145–8152. 82 indexed citations

13.

Pine, Polly, Betty Chang, Nathan Schoettler, et al.. (2007). Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. Clinical Immunology. 124(3). 244–257. 170 indexed citations

14.

Cha, Hoon‐Suk, David L. Boyle, Tomoyuki Inoue, et al.. (2006). A Novel Spleen Tyrosine Kinase Inhibitor Blocks c-Jun N-Terminal Kinase-Mediated Gene Expression in Synoviocytes. Journal of Pharmacology and Experimental Therapeutics. 317(2). 571–578. 120 indexed citations

15.

Matsubara, Shigeki, Guiming Li, Katsuyuki Takeda, et al.. (2005). Inhibition of Spleen Tyrosine Kinase Prevents Mast Cell Activation and Airway Hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine. 173(1). 56–63. 79 indexed citations

16.

Matsubara, Shigeki, Toshiyuki Koya, Katsuyuki Takeda, et al.. (2005). Syk Activation in Dendritic Cells Is Essential for Airway Hyperresponsiveness and Inflammation. American Journal of Respiratory Cell and Molecular Biology. 34(4). 426–433. 67 indexed citations

17.

Pine, Polly, et al.. (2005). An Orally Bioavailable Inhibitor of FLT3 and Syk Kinases Prevents Tumor Growth in Subcutaneously Implanted Human Tumor Xenografts and Promotes Cell Death of FLT3 Mutant AML Cells.. Blood. 106(11). 243–243. 6 indexed citations

18.

Chen, Xiaoying, et al.. (1998). Oncocidin A1: a novel tubulin-binding drug with antitumor activity against human breast and ovarian carcinoma xenografts in nude mice. Biochemical Pharmacology. 56(5). 623–633. 14 indexed citations

19.

Dawson, Marcia I., Wan‐Ru Chao, Polly Pine, et al.. (1995). Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.. PubMed. 55(19). 4446–51. 67 indexed citations

20.

Shoeman, Robert L., D B Young, Raveendran Pottathil, et al.. (1987). Comparison of recombinant human immunodeficiency virus gag precursor and fusion proteins and a synthetic env peptide as diagnostic reagents. Analytical Biochemistry. 161(2). 370–379. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact